Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04547439
PHASE2
Sleep, Diabetic Retinopathy and Melatonin
Sponsor: University of Illinois at Chicago
View on ClinicalTrials.gov
Summary
This study explores the use of melatonin in patients with diabetic retinopathy
Official title: Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation
Key Details
Gender
All
Age Range
40 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2021-02-03
Completion Date
2026-06
Last Updated
2025-08-12
Healthy Volunteers
No
Conditions
Interventions
DRUG
Melatonin
Melatonin 3 mg will be taken nightly for 8 weeks
OTHER
Placebo
Placebo will be given nightly for 8 weeks
Locations (1)
University of Illinois at Chicago
Chicago, Illinois, United States